Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s12943-017-0621-z.

Title:
Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways | Molecular Cancer
Description:
Background Inflammatory breast cancer (IBC), a particularly aggressive form of breast cancer, is characterized by cancer stem cell (CSC) phenotype. Due to a lack of targeted therapies, the identification of molecular markers of IBC is of major importance. The heparan sulfate proteoglycan Syndecan-1 acts as a coreceptor for growth factors and chemokines, modulating inflammation, tumor progression, and cancer stemness, thus it may emerge as a molecular marker for IBC. Methods We characterized expression of Syndecan-1 and the CSC marker CD44, Notch-1 & -3 and EGFR in carcinoma tissues of triple negative IBC (n = 13) and non-IBC (n = 17) patients using qPCR and immunohistochemistry. Impact of siRNA-mediated Syndecan-1 knockdown on the CSC phenotype of the human triple negative IBC cell line SUM-149 and HER-2-overexpressing non-IBC SKBR3 cells employing qPCR, flow cytometry, Western blotting, secretome profiling and Notch pharmacological inhibition experiments. Data were statistically analyzed using Student’s t-test/Mann-Whitney U-test or one-way ANOVA followed by Tukey’s multiple comparison tests. Results Our data indicate upregulation and a significant positive correlation of Syndecan-1 with CD44 protein, and Notch-1 & -3 and EGFR mRNA in IBC vs non-IBC. ALDH1 activity and the CD44(+)CD24(-/low) subset as readout of a CSC phenotype were reduced upon Syndecan-1 knockdown. Functionally, Syndecan-1 silencing significantly reduced 3D spheroid and colony formation. Intriguingly, qPCR results indicate downregulation of the IL-6, IL-8, CCL20, gp130 and EGFR mRNA upon Syndecan-1 suppression in both cell lines. Moreover, Syndecan-1 silencing significantly downregulated Notch-1, -3, -4 and Hey-1 in SUM-149 cells, and downregulated only Notch-3 and Gli-1 mRNA in SKBR3 cells. Secretome profiling unveiled reduced IL-6, IL-8, GRO-alpha and GRO a/b/g cytokines in conditioned media of Syndecan-1 knockdown SUM-149 cells compared to controls. The constitutively activated STAT3 and NFÎșB, and expression of gp130, Notch-1 & -2, and EGFR proteins were suppressed upon Syndecan-1 ablation. Mechanistically, gamma-secretase inhibition experiments suggested that Syndecan-1 may regulate the expression of IL-6, IL-8, gp130, Hey-1, EGFR and p-Akt via Notch signaling. Conclusions Syndecan-1 acts as a novel tissue biomarker and a modulator of CSC phenotype of triple negative IBC via the IL-6/STAT3, Notch and EGFR signaling pathways, thus emerging as a promising therapeutic target for IBC.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💾}

We don’t know how the website earns money.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

syndecan, cells, cancer, pubmed, breast, expression, ibc, notch, article, sum, google, scholar, cell, egfr, nonibc, control, signaling, data, skbr, cas, fig, patients, mrna, negative, inflammatory, tissues, csc, knockdown, central, triple, tumor, positive, growth, carcinoma, silencing, levels, formation, phenotype, correlation, stem, van, flow, compared, analysis, stat, size, sirna, res, pathways, significantly,

Topics {✒}

t-test/mann-whitney u-test nuclear factor-kappab dna-binding il6/jak1/stat3 signaling blockade nf-kappab/p65 signaling pathway syndecan-1 modulates beta-integrin-dependent quantitative real-time pcr stabilizing tumour-initiating cells martin götte nuclear factor-kappab signature anti-human-notch-2-pe & apc stem/progenitor cell properties mann-whitney u-test nf-kappab collaboration potential microenvironmental biomarkers carcinogen-induced tumor development article download pdf van golen kl triple-negative breast cancer transmembrane c-terminal fragment population-based cancer registry nf-kappab activation lung metastasis formation mmtv-pymt mouse model map kinase-dependent process mouse anti-human syndecan-1 rnai-mediated syndecan-1 silencing patient-derived xenograft tumors cultrex-coated petri-dishes cultrex-coated petri dishes raybio cytokine array-c3 lung cancer model sirna-mediated syndecan-1 knockdown autocrine feedback loop e-cadherin-dependent mechanism large population-based study triple negative mda-mb-23 jak2/stat3 signaling pathway cytoplasmic c-terminal fragment hrp–conjugated secondary antibodies cancer stem cell downstream signaling p-akt il-6-mediated stat3 signaling syndecan-1-silenced cells displayed anti-human-cd24-pe gamma-secretase inhibitor treatment wnt-1-induced mammary tumorigenesis il-6/jak2/stat3 pathway inflammatory breast cancer sherif abdelaziz ibrahim anti-human-cd44-fitc

Questions {❓}

  • Notch signaling as a therapeutic target for breast cancer treatment?

Schema {đŸ—ș}

WebPage:
      mainEntity:
         headline:Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
         description:Inflammatory breast cancer (IBC), a particularly aggressive form of breast cancer, is characterized by cancer stem cell (CSC) phenotype. Due to a lack of targeted therapies, the identification of molecular markers of IBC is of major importance. The heparan sulfate proteoglycan Syndecan-1 acts as a coreceptor for growth factors and chemokines, modulating inflammation, tumor progression, and cancer stemness, thus it may emerge as a molecular marker for IBC. We characterized expression of Syndecan-1 and the CSC marker CD44, Notch-1 & -3 and EGFR in carcinoma tissues of triple negative IBC (n = 13) and non-IBC (n = 17) patients using qPCR and immunohistochemistry. Impact of siRNA-mediated Syndecan-1 knockdown on the CSC phenotype of the human triple negative IBC cell line SUM-149 and HER-2-overexpressing non-IBC SKBR3 cells employing qPCR, flow cytometry, Western blotting, secretome profiling and Notch pharmacological inhibition experiments. Data were statistically analyzed using Student’s t-test/Mann-Whitney U-test or one-way ANOVA followed by Tukey’s multiple comparison tests. Our data indicate upregulation and a significant positive correlation of Syndecan-1 with CD44 protein, and Notch-1 & -3 and EGFR mRNA in IBC vs non-IBC. ALDH1 activity and the CD44(+)CD24(-/low) subset as readout of a CSC phenotype were reduced upon Syndecan-1 knockdown. Functionally, Syndecan-1 silencing significantly reduced 3D spheroid and colony formation. Intriguingly, qPCR results indicate downregulation of the IL-6, IL-8, CCL20, gp130 and EGFR mRNA upon Syndecan-1 suppression in both cell lines. Moreover, Syndecan-1 silencing significantly downregulated Notch-1, -3, -4 and Hey-1 in SUM-149 cells, and downregulated only Notch-3 and Gli-1 mRNA in SKBR3 cells. Secretome profiling unveiled reduced IL-6, IL-8, GRO-alpha and GRO a/b/g cytokines in conditioned media of Syndecan-1 knockdown SUM-149 cells compared to controls. The constitutively activated STAT3 and NFÎșB, and expression of gp130, Notch-1 & -2, and EGFR proteins were suppressed upon Syndecan-1 ablation. Mechanistically, gamma-secretase inhibition experiments suggested that Syndecan-1 may regulate the expression of IL-6, IL-8, gp130, Hey-1, EGFR and p-Akt via Notch signaling. Syndecan-1 acts as a novel tissue biomarker and a modulator of CSC phenotype of triple negative IBC via the IL-6/STAT3, Notch and EGFR signaling pathways, thus emerging as a promising therapeutic target for IBC.
         datePublished:2017-03-07T00:00:00Z
         dateModified:2017-03-07T00:00:00Z
         pageStart:1
         pageEnd:19
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12943-017-0621-z
         keywords:
            Inflammatory breast cancer
            Syndecan-1
            Proteoglycan
            Cancer stem cell
            IL-6/STAT3
            Notch
            EGFR
            Cancer Research
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-017-0621-z/MediaObjects/12943_2017_621_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-017-0621-z/MediaObjects/12943_2017_621_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-017-0621-z/MediaObjects/12943_2017_621_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-017-0621-z/MediaObjects/12943_2017_621_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-017-0621-z/MediaObjects/12943_2017_621_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-017-0621-z/MediaObjects/12943_2017_621_Fig6_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-017-0621-z/MediaObjects/12943_2017_621_Fig7_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-017-0621-z/MediaObjects/12943_2017_621_Fig8_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-017-0621-z/MediaObjects/12943_2017_621_Fig9_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-017-0621-z/MediaObjects/12943_2017_621_Fig10_HTML.gif
         isPartOf:
            name:Molecular Cancer
            issn:
               1476-4598
            volumeNumber:16
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Sherif Abdelaziz Ibrahim
               affiliation:
                     name:Cairo University
                     address:
                        name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Ramy Gadalla
               affiliation:
                     name:Cairo University
                     address:
                        name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Eslam A. El-Ghonaimy
               affiliation:
                     name:Cairo University
                     address:
                        name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Omnia Samir
               affiliation:
                     name:Cairo University
                     address:
                        name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hossam Taha Mohamed
               affiliation:
                     name:Cairo University
                     address:
                        name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hebatallah Hassan
               affiliation:
                     name:Cairo University
                     address:
                        name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Burkhard Greve
               affiliation:
                     name:University Hospital MĂŒnster
                     address:
                        name:Department of Radiotherapy–Radiooncology, University Hospital MĂŒnster, MĂŒnster, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mohamed El-Shinawi
               affiliation:
                     name:Ain Shams University
                     address:
                        name:Department of General Surgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mona Mostafa Mohamed
               affiliation:
                     name:Cairo University
                     address:
                        name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Martin Götte
               affiliation:
                     name:MĂŒnster University Hospital
                     address:
                        name:Department of Gynecology and Obstetrics, MĂŒnster University Hospital, MĂŒnster, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
      description:Inflammatory breast cancer (IBC), a particularly aggressive form of breast cancer, is characterized by cancer stem cell (CSC) phenotype. Due to a lack of targeted therapies, the identification of molecular markers of IBC is of major importance. The heparan sulfate proteoglycan Syndecan-1 acts as a coreceptor for growth factors and chemokines, modulating inflammation, tumor progression, and cancer stemness, thus it may emerge as a molecular marker for IBC. We characterized expression of Syndecan-1 and the CSC marker CD44, Notch-1 & -3 and EGFR in carcinoma tissues of triple negative IBC (n = 13) and non-IBC (n = 17) patients using qPCR and immunohistochemistry. Impact of siRNA-mediated Syndecan-1 knockdown on the CSC phenotype of the human triple negative IBC cell line SUM-149 and HER-2-overexpressing non-IBC SKBR3 cells employing qPCR, flow cytometry, Western blotting, secretome profiling and Notch pharmacological inhibition experiments. Data were statistically analyzed using Student’s t-test/Mann-Whitney U-test or one-way ANOVA followed by Tukey’s multiple comparison tests. Our data indicate upregulation and a significant positive correlation of Syndecan-1 with CD44 protein, and Notch-1 & -3 and EGFR mRNA in IBC vs non-IBC. ALDH1 activity and the CD44(+)CD24(-/low) subset as readout of a CSC phenotype were reduced upon Syndecan-1 knockdown. Functionally, Syndecan-1 silencing significantly reduced 3D spheroid and colony formation. Intriguingly, qPCR results indicate downregulation of the IL-6, IL-8, CCL20, gp130 and EGFR mRNA upon Syndecan-1 suppression in both cell lines. Moreover, Syndecan-1 silencing significantly downregulated Notch-1, -3, -4 and Hey-1 in SUM-149 cells, and downregulated only Notch-3 and Gli-1 mRNA in SKBR3 cells. Secretome profiling unveiled reduced IL-6, IL-8, GRO-alpha and GRO a/b/g cytokines in conditioned media of Syndecan-1 knockdown SUM-149 cells compared to controls. The constitutively activated STAT3 and NFÎșB, and expression of gp130, Notch-1 & -2, and EGFR proteins were suppressed upon Syndecan-1 ablation. Mechanistically, gamma-secretase inhibition experiments suggested that Syndecan-1 may regulate the expression of IL-6, IL-8, gp130, Hey-1, EGFR and p-Akt via Notch signaling. Syndecan-1 acts as a novel tissue biomarker and a modulator of CSC phenotype of triple negative IBC via the IL-6/STAT3, Notch and EGFR signaling pathways, thus emerging as a promising therapeutic target for IBC.
      datePublished:2017-03-07T00:00:00Z
      dateModified:2017-03-07T00:00:00Z
      pageStart:1
      pageEnd:19
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12943-017-0621-z
      keywords:
         Inflammatory breast cancer
         Syndecan-1
         Proteoglycan
         Cancer stem cell
         IL-6/STAT3
         Notch
         EGFR
         Cancer Research
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-017-0621-z/MediaObjects/12943_2017_621_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-017-0621-z/MediaObjects/12943_2017_621_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-017-0621-z/MediaObjects/12943_2017_621_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-017-0621-z/MediaObjects/12943_2017_621_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-017-0621-z/MediaObjects/12943_2017_621_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-017-0621-z/MediaObjects/12943_2017_621_Fig6_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-017-0621-z/MediaObjects/12943_2017_621_Fig7_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-017-0621-z/MediaObjects/12943_2017_621_Fig8_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-017-0621-z/MediaObjects/12943_2017_621_Fig9_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-017-0621-z/MediaObjects/12943_2017_621_Fig10_HTML.gif
      isPartOf:
         name:Molecular Cancer
         issn:
            1476-4598
         volumeNumber:16
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Sherif Abdelaziz Ibrahim
            affiliation:
                  name:Cairo University
                  address:
                     name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Ramy Gadalla
            affiliation:
                  name:Cairo University
                  address:
                     name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Eslam A. El-Ghonaimy
            affiliation:
                  name:Cairo University
                  address:
                     name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Omnia Samir
            affiliation:
                  name:Cairo University
                  address:
                     name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hossam Taha Mohamed
            affiliation:
                  name:Cairo University
                  address:
                     name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hebatallah Hassan
            affiliation:
                  name:Cairo University
                  address:
                     name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Burkhard Greve
            affiliation:
                  name:University Hospital MĂŒnster
                  address:
                     name:Department of Radiotherapy–Radiooncology, University Hospital MĂŒnster, MĂŒnster, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mohamed El-Shinawi
            affiliation:
                  name:Ain Shams University
                  address:
                     name:Department of General Surgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mona Mostafa Mohamed
            affiliation:
                  name:Cairo University
                  address:
                     name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Martin Götte
            affiliation:
                  name:MĂŒnster University Hospital
                  address:
                     name:Department of Gynecology and Obstetrics, MĂŒnster University Hospital, MĂŒnster, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Molecular Cancer
      issn:
         1476-4598
      volumeNumber:16
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Cairo University
      address:
         name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
         type:PostalAddress
      name:Cairo University
      address:
         name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
         type:PostalAddress
      name:Cairo University
      address:
         name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
         type:PostalAddress
      name:Cairo University
      address:
         name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
         type:PostalAddress
      name:Cairo University
      address:
         name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
         type:PostalAddress
      name:Cairo University
      address:
         name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
         type:PostalAddress
      name:University Hospital MĂŒnster
      address:
         name:Department of Radiotherapy–Radiooncology, University Hospital MĂŒnster, MĂŒnster, Germany
         type:PostalAddress
      name:Ain Shams University
      address:
         name:Department of General Surgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt
         type:PostalAddress
      name:Cairo University
      address:
         name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
         type:PostalAddress
      name:MĂŒnster University Hospital
      address:
         name:Department of Gynecology and Obstetrics, MĂŒnster University Hospital, MĂŒnster, Germany
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Sherif Abdelaziz Ibrahim
      affiliation:
            name:Cairo University
            address:
               name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Ramy Gadalla
      affiliation:
            name:Cairo University
            address:
               name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
               type:PostalAddress
            type:Organization
      name:Eslam A. El-Ghonaimy
      affiliation:
            name:Cairo University
            address:
               name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
               type:PostalAddress
            type:Organization
      name:Omnia Samir
      affiliation:
            name:Cairo University
            address:
               name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
               type:PostalAddress
            type:Organization
      name:Hossam Taha Mohamed
      affiliation:
            name:Cairo University
            address:
               name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
               type:PostalAddress
            type:Organization
      name:Hebatallah Hassan
      affiliation:
            name:Cairo University
            address:
               name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
               type:PostalAddress
            type:Organization
      name:Burkhard Greve
      affiliation:
            name:University Hospital MĂŒnster
            address:
               name:Department of Radiotherapy–Radiooncology, University Hospital MĂŒnster, MĂŒnster, Germany
               type:PostalAddress
            type:Organization
      name:Mohamed El-Shinawi
      affiliation:
            name:Ain Shams University
            address:
               name:Department of General Surgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt
               type:PostalAddress
            type:Organization
      name:Mona Mostafa Mohamed
      affiliation:
            name:Cairo University
            address:
               name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
               type:PostalAddress
            type:Organization
      name:Martin Götte
      affiliation:
            name:MĂŒnster University Hospital
            address:
               name:Department of Gynecology and Obstetrics, MĂŒnster University Hospital, MĂŒnster, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
      name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
      name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
      name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
      name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
      name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
      name:Department of Radiotherapy–Radiooncology, University Hospital MĂŒnster, MĂŒnster, Germany
      name:Department of General Surgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt
      name:Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt
      name:Department of Gynecology and Obstetrics, MĂŒnster University Hospital, MĂŒnster, Germany

External Links {🔗}(299)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Foundation
  • Prism.js

CDN Services {📩}

  • Crossref

5.37s.